OptiPAP Junior for Bronchopulmonary Dysplasia
What You Need to Know Before You Apply
What is the purpose of this trial?
To evaluate how different forms of respiratory support affect parent interaction, how parents feel about different methods of support, and how their child's current respiratory support level is perceived in the setting of long-term outcomes.
Are You a Good Fit for This Trial?
This trial is for parents of premature babies with lung problems like bronchopulmonary dysplasia who are receiving breathing support using nasal CPAP devices. The study focuses on families whose infants need this type of respiratory help.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- FlexiTrunk
- OptiPAP Junior
Trial Overview
The trial compares two types of nasal CPAP interfaces—OptiPAP Junior and FlexiTrunk—to see how each affects parent-child interaction, parental feelings about the device, and perceptions of their child's breathing support.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The OptiPAP Junior device (Fisher \& Paykel) is an FDA cleared device interface for the provision of pressure-based respiratory support to be used in accordance with its approved labeling.
The Flexitrunk (Fisher \& Paykel) is a predominant interface used in neonatal care units. Flexitrunk is an FDA cleared device interface for the provision of pressure-based respiratory support to be used in accordance with its approved labeling.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sharp HealthCare
Lead Sponsor
Fisher & Paykel
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.